No Data
No Data
FibroBiologics to Present at JonesTrading Healthcare Summit 2024
HOUSTON, July 15, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of
Express News | FibroBiologics Highlights Preliminary Proof-Of-Concept For Novel Artificial Thymus Organoid Technology
Express News | Fibrobiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
FibroBiologics Files for 16.02M Shares of Common Stock by Selling Shareholder
Express News | FibroBiologics Files Prospectus Relates To Resale Of Up To 16M Shares Of Common Stock By GEM
Express News | Fibrobiologics Inc Files Rospectus Relates to Resale of up to 16 Mln Shares of Common Stock by Gem - SEC Filing
No Data